Inspiratory Muscle Training in Postmenopausal Women
Launched by INDIANA UNIVERSITY · Jun 10, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of exercise, called inspiratory muscle strength training, can improve heart health and mood in postmenopausal women. The goal is to see if strengthening the muscles we use to breathe can have positive effects on overall well-being, especially for women who are experiencing symptoms related to aging and obesity.
To participate, women must be between 50 and 75 years old, have been postmenopausal for at least six years, and have a body mass index (BMI) between 25 and 39.9. Participants should be able to walk without help and own a Bluetooth-capable phone or tablet. The study is currently looking for volunteers, and those who join can expect to engage in a training program focused on breathing exercises. However, certain health conditions, such as high blood pressure or a history of heart problems, may prevent someone from participating. If you're interested in improving your heart health and mood through this unique exercise, this trial might be a great opportunity!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postmenopausal women (self-report at least 6 years since last menstrual cycle)
- • Aged 50-75 years (confirmed by birth date listed on participant's driver license at screening visit)
- • English-speaking
- • Body mass index between 25.0 to 39.9 kg/m2
- • Able to ambulate without assistance
- • Own or have access to a Bluetooth-capable phone or tablet (IOS version 12.0 or later or Android version 7.0 or later)
- Exclusion Criteria:
- • Unable to provide informed consent.
- • Greater than stage II hypertension (i.e., \>159/99 mm Hg)
- • Current tobacco use (self-report)
- • Habitually exercise training ≥ 2 days per week (self-report)
- • Significant orthopedic limitations or other contraindications to strenuous exercise
- • Live or work \> 80 miles from Bloomington, Indiana
- • Anticipated elective surgery during the study period.
- • Surgery to the chest or abdomen in the last 6 months.
- • Plan to move residence or travel out of the local area during the study period.
- • History of heart attack or heart condition.
- • Current use of prescription medications that affect heart rate or blood vessel dilation (e.g., systemic b-adrenergic blockers, calcium channel blockers, and hormone replacement therapy).
- • Diagnosis of asthma or chronic pulmonary disease.
- • Current respiratory infection.
- • Diagnosis of an aneurysm in the chest, abdomen, or brain.
- • Psychological or social characteristics that would interfere with their ability to fully participate in the study.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bloomington, Indiana, United States
Patients applied
Trial Officials
Stephen J Carter, Ph.D
Principal Investigator
Indiana University, Bloomington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported